Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Joffre Baker, Felix Baker, Steve Shak

Premium

As of July 26, Joffre Baker has left his position as chief scientific officer of Genomic Health and become a senior fellow at the company. Effective the same date, chief medical officer Steven Shak has taken on responsibilities for managing Genomic Health's research operations that were previously managed by Baker. In addition to being the chief medical officer, Shak has the additional title of executive VP of research and development.

Genomic Health's board of directors has also elected Felix Baker as a member of the board. Baker is a managing partner and co-founder of Baker Brothers Investments.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.